title: Beginning antiretroviral therapy for patients with HIV.
abstract: In this article, we review the options for initial antiretroviral therapy, including the data from clinical trials to support these choices and the factors to consider in selection of a regimen to best fit each patient.
authors.affiliation: Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, PBBA4, Boston, MA 02115, USA. Electronic address: jjohnson30@partners.org.
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Johnson
authors.affiliation: Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, PBBA4, Boston, MA 02115, USA.
authors.forename: Paul E
authors.initials: PE
authors.lastname: Sax
mesh_terms: D044966:Anti-Retroviral Agents / Q000008:administration & dosage* / Q000009:adverse effects; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects / Q000379:methods*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D055118:Medication Adherence
chemical_list: D044966:Anti-Retroviral Agents
keywords: Antiretroviral therapy (ART); HIV; Integrase strand transfer inhibitor (INSTI); Nonnucleoside reverse transcriptase inhibitor (NNRTI); Nucleoside/nucleotide reverse transcriptase inhibitor (NRTI); Protease inhibitor (PI); Treatment-naïve